Literature DB >> 24694578

Risk of irritable bowel syndrome in first-degree, second-degree and third-degree relatives of affected individuals: a nationwide family study in Sweden.

Rasmus Waehrens1, Henrik Ohlsson1, Jan Sundquist2, Kristina Sundquist2, Bengt Zöller1.   

Abstract

OBJECTIVES: IBS aggregates in families, but the familial risk of IBS has only been determined in first-degree relatives and spouses. This nationwide study aimed to determine the familial risk of IBS in first-degree, second-degree, and third-degree relatives and spouses of affected individuals in order to estimate the relative influences of genes and shared family environment.
METHODS: We performed a case-cohort study. The Swedish Multigeneration Register was linked to the Hospital Discharge Register for the period 1987-2010 and the Swedish Outpatient Care Register for 2001-2010. ORs for IBS were calculated for relatives of individuals who had been diagnosed with IBS compared with relatives of individuals unaffected by IBS as the reference group. ORs were also determined for IBS cases diagnosed in primary healthcare in four Swedish counties (2001-2007).
RESULTS: The ORs for IBS were 1.75 in siblings (95% CI 1.63 to 1.89), 1.82 in offspring (1.67 to 1.97), 1.90 in parents (1.76 to 2.05), 1.10 in maternal half-siblings (0.88 to 1.39), 1.78 in paternal half-siblings (1.48 to 2.15), 1.27 in nieces/nephews (1.18 to 1.38), 1.11 in cousins (1.04 to 1.18), and 1.51 in spouses (1.24 to 1.84) of probands diagnosed with IBS. The OR for probands diagnosed in primary healthcare was 1.82 in siblings (1.52 to 2.18), and 1.82 in offspring (1.49 to 2.21).
CONCLUSIONS: The increased IBS risk among first-degree relatives and also second-degree and third-degree relatives indicates a genetic component of the familial clustering of IBS. However, a non-genetic contribution is also suggested by the increased risk among spouses. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2014        PMID: 24694578     DOI: 10.1136/gutjnl-2013-305705

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Immune Activation in Functional Gastrointestinal Disorders.

Authors:  Grace Burns; Jennifer Pryor; Gerald Holtmann; Marjorie M Walker; Nicholas J Talley; Simon Keely
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

Review 2.  Recent developments in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.

Authors:  Michael Camilleri; Alexandra Zhernakova; Isotta Bozzarelli; Mauro D'Amato
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08-10       Impact factor: 73.082

Review 4.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 5.  Genetic epidemiology of irritable bowel syndrome.

Authors:  Jasbir Makker; Sridhar Chilimuri; Jonathan N Bella
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

6.  Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome.

Authors:  Ferdinando Bonfiglio; Tenghao Zheng; Koldo Garcia-Etxebarria; Fatemeh Hadizadeh; Luis Bujanda; Francesca Bresso; Lars Agreus; Anna Andreasson; Aldona Dlugosz; Greger Lindberg; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Magnus Simren; Susanna Walter; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Anna Latiano; Matthias Hübenthal; Vincent Thijs; Mihai G Netea; Daisy Jonkers; Lin Chang; Emeran A Mayer; Mira M Wouters; Guy Boeckxstaens; Michael Camilleri; Andre Franke; Alexandra Zhernakova; Mauro D'Amato
Journal:  Gastroenterology       Date:  2018-04-05       Impact factor: 22.682

Review 7.  Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders.

Authors:  Susrutha Puthanmadhom Narayanan; Bradley Anderson; Adil E Bharucha
Journal:  Mayo Clin Proc       Date:  2021-04       Impact factor: 7.616

8.  Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern.

Authors:  Anil S Sarica; Serhat Bor; Mehmet N Orman; Hector Barajas-Martinez; Jyh-Ming Jimmy Juang; Charles Antzelevitch; Can Hasdemir
Journal:  Am J Cardiol       Date:  2021-05-24       Impact factor: 3.133

9.  Genetics of irritable bowel syndrome.

Authors:  Maria Henström; Mauro D'Amato
Journal:  Mol Cell Pediatr       Date:  2016-02-12

10.  A Swedish national adoption study of risk of irritable bowel syndrome (IBS).

Authors:  Rasmus Waehrens; Bengt Zöller; Jan Sundquist; Kristina Sundquist; MirNabi Pirouzifard
Journal:  BMJ Open Gastroenterol       Date:  2017-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.